FDA Inspection 1214460 — Virginia Commonwealth University Medical Center, Transfusion

Virginia Commonwealth University Medical Center, Transfusion — FEI 1171788

The FDA completed an inspection of Virginia Commonwealth University Medical Center, Transfusion on July 26, 2023 in Richmond, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Richmond, VA (United States)